Can a mushroom pill ease Chemo's toll? small study investigates
NCT ID NCT05763199
Summary
This small pilot study is testing whether a daily mushroom extract supplement (AHCC) can improve quality of life for women with ovarian, fallopian tube, or peritoneal cancer who are undergoing standard chemotherapy. Twenty participants will be randomly assigned to take either the mushroom extract or a placebo pill during their treatment. The main goal is to see if it's practical to run a larger study, while also checking if the supplement helps with symptoms like fatigue and nerve problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.